The Allstate Corporation $ALL Stock Holdings Lessened by Burney Co.

Burney Co. cut its holdings in The Allstate Corporation (NYSE:ALLFree Report) by 1.3% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 32,402 shares of the insurance provider’s stock after selling 441 shares during the period. Burney Co.’s holdings in Allstate were worth $6,523,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently bought and sold shares of ALL. Vanguard Group Inc. boosted its stake in Allstate by 0.5% in the first quarter. Vanguard Group Inc. now owns 32,800,086 shares of the insurance provider’s stock valued at $6,791,914,000 after acquiring an additional 164,662 shares during the period. Price T Rowe Associates Inc. MD raised its position in shares of Allstate by 25.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 11,709,610 shares of the insurance provider’s stock worth $2,424,710,000 after purchasing an additional 2,374,684 shares during the period. GQG Partners LLC lifted its holdings in shares of Allstate by 2.1% in the 1st quarter. GQG Partners LLC now owns 4,405,701 shares of the insurance provider’s stock worth $912,288,000 after purchasing an additional 89,185 shares during the last quarter. Boston Partners boosted its position in Allstate by 613.9% during the 1st quarter. Boston Partners now owns 2,482,654 shares of the insurance provider’s stock valued at $512,627,000 after purchasing an additional 2,134,893 shares during the period. Finally, Goldman Sachs Group Inc. grew its stake in Allstate by 27.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 2,328,070 shares of the insurance provider’s stock worth $482,073,000 after buying an additional 497,982 shares during the last quarter. Institutional investors and hedge funds own 76.47% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on ALL shares. JPMorgan Chase & Co. raised their target price on Allstate from $235.00 to $254.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Evercore ISI set a $233.00 price objective on shares of Allstate and gave the company an “in-line” rating in a research report on Wednesday, October 1st. Jefferies Financial Group boosted their target price on shares of Allstate from $254.00 to $255.00 and gave the company a “buy” rating in a research note on Monday, August 11th. Wolfe Research raised Allstate to a “strong-buy” rating in a report on Tuesday, September 16th. Finally, Roth Capital set a $230.00 price objective on Allstate and gave the stock a “buy” rating in a research report on Friday, September 26th. Two equities research analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $234.27.

Read Our Latest Stock Report on ALL

Allstate Trading Down 0.1%

Shares of NYSE:ALL opened at $191.71 on Monday. The company has a 50 day moving average of $202.56 and a 200-day moving average of $201.12. The company has a current ratio of 0.43, a quick ratio of 0.43 and a debt-to-equity ratio of 0.37. The firm has a market cap of $50.52 billion, a P/E ratio of 9.01, a P/E/G ratio of 0.69 and a beta of 0.38. The Allstate Corporation has a twelve month low of $176.00 and a twelve month high of $215.70.

About Allstate

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Featured Articles

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.